H
HROW
Harrow Health Inc
28.76
-0.19-0.66%Opening11:00 10/27 EDT
OPEN/PREV CLOSE29.10/28.95
TODAY RANGE28.44-29.10
VOL259.63K
MARKET CAP1.08B
52 WEEK RANGE26.96-54.85
AVG VOL (3M)570.24K
% TURNOVER0.69%
TURNOVER--
P/E (TTM)-28.7729
% RANGE2.30%
EPS(TTM)-0.9999
P/E(FORWARD)-268.5272
P/B70.95
BVPS0.4055
DIVIDEND--
P/S3.933
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP912.36M
SHARES OUTSTANDING37.49M
NEXT EARNINGS11/09-11/13
FREE FLOAT31.71M
LOT SIZE1
EX-DATE02/08/2013
News
Press Releases
Financial Reports
Profile
Seeking Alpha·4d ago
Harrow: The Second Half Has Too Much To Do
Seeking Alpha·10/12 10:29
Viatris: Improved Confidence Drives M&A Action Again
NASDAQ·10/09 11:46
Do Options Traders Know Something About Harrow Stock We Don't?
Seeking Alpha·10/08 12:46
Harrow: Q3 Needs To Prove The Turnaround Is Real
Dow Jones·10/07 10:00
Harrow Price Target Maintained With a $63.00/Share by BTIG
Benzinga·10/07 09:50
BTIG Reiterates Buy on Harrow, Maintains $63 Price Target
TipRanks·10/05 13:16
Lake Street Keeps Their Buy Rating on Harrow Health (HROW)
TipRanks·10/05 11:57
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio
Dow Jones·10/05 11:00
Press Release: Harrow Closes Acquisition of TYRVAYA(R)
Seeking Alpha·10/01 16:01
William Blair refreshes its analyst conviction list
TipRanks·09/30 09:15
Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)
Benzinga·09/25 20:19
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
NASDAQ·09/09 23:32
Leerink Partners Initiates Coverage of Harrow at Outperform
Dow Jones·09/09 15:28
Harrow Initiated at Outperform by Leerink Partners
Same Industry
Name/Symbol
Change%
Price